Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 675

1.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

2.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium.

Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.

3.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS.

Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.

4.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

5.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators.

Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.

6.

Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J.

Am J Kidney Dis. 2012 May;59(5):653-62. doi: 10.1053/j.ajkd.2011.11.042. Epub 2012 Feb 4.

7.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.

Foster MC, Levey AS, Inker LA, Shafi T, Fan L, Gudnason V, Katz R, Mitchell GF, Okparavero A, Palsson R, Post WS, Shlipak MG.

Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.

8.

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium.

Am J Kidney Dis. 2013 Jul;62(1):42-51. doi: 10.1053/j.ajkd.2013.01.016. Epub 2013 Mar 19.

9.

Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group.

Am J Kidney Dis. 2011 Dec;58(6):886-93. doi: 10.1053/j.ajkd.2011.07.018. Epub 2011 Sep 22.

10.

Change in novel filtration markers and risk of ESRD.

Rebholz CM, Grams ME, Matsushita K, Selvin E, Coresh J.

Am J Kidney Dis. 2015 Jul;66(1):47-54. doi: 10.1053/j.ajkd.2014.11.009. Epub 2014 Dec 24.

11.

Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.

Werner K, Pihlsgård M, Elmståhl S, Legrand H, Nyman U, Christensson A.

Nephron. 2017;137(1):29-37. doi: 10.1159/000473703. Epub 2017 Apr 14.

PMID:
28407629
12.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

13.

Comparison of the new and traditional CKD-EPI GFR estimation equations with urinary inulin clearance: A study of equation performance.

White CA, Allen CM, Akbari A, Collier CP, Holland DC, Day AG, Knoll GA.

Clin Chim Acta. 2019 Jan;488:189-195. doi: 10.1016/j.cca.2018.11.019. Epub 2018 Nov 13.

PMID:
30445029
14.

Effects of Traumatic Amputation on β-Trace Protein and β2-Microglobulin Concentrations in Male Soldiers.

Little DJ, Yuan CM, Thurlow JS, Gounden V, Doi SQ, Pruziner A, Abbott KC, Theeler BJ, Olson SW.

Am J Nephrol. 2015;42(6):436-42. doi: 10.1159/000443775. Epub 2016 Jan 23.

15.

Can the new CKD-EPI BTP-B2M formula be applied in children?

Filler G, Alvarez-Elías AC, Westreich KD, Huang SS, Lindsay RM.

Pediatr Nephrol. 2016 Dec;31(12):2175-2177. Epub 2016 Sep 19.

PMID:
27647182
16.

Novel Filtration Markers for GFR Estimation.

Karger AB, Inker LA, Coresh J, Levey AS, Eckfeldt JH.

EJIFCC. 2017 Dec 19;28(4):277-288. eCollection 2017 Dec.

17.

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.

Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Diouf M, Choukroun G, Massy ZA; European Uremic Toxin Work Group (EUTox).

Kidney Int. 2012 Dec;82(12):1297-303. doi: 10.1038/ki.2012.301. Epub 2012 Aug 15.

18.

Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Grams ME, Yang W, Rebholz CM, Wang X, Porter AC, Inker LA, Horwitz E, Sondheimer JH, Hamm LL, He J, Weir MR, Jaar BG, Shafi T, Appel LJ, Hsu CY; CRIC Study Investigators.

Am J Kidney Dis. 2017 Sep;70(3):337-346. doi: 10.1053/j.ajkd.2017.01.050. Epub 2017 Mar 30.

19.

Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.

Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1770-7. doi: 10.1161/ATVBAHA.114.303465. Epub 2014 May 29.

20.

Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.

Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F.

Am J Cardiol. 2012 Nov 1;110(9):1240-8. doi: 10.1016/j.amjcard.2012.06.027. Epub 2012 Jul 19.

PMID:
22818840

Supplemental Content

Support Center